Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WNK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IKZF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYBBP1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF581 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ADSL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BOLA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTMR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPB41L4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIFAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKAG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on